NCT00402636View on ClinicalTrials.gov

Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)

PHASE4CompletedINTERVENTIONAL
Enrollment

502

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

October 31, 2006

Conditions
Coronary Heart Disease
Interventions
DEVICE

rapamycin plus 17beta estradiolvalerat-eluting stent

rapamycin plus 17beta estradiolvalerat-eluting stent was implanted due to randomisation

DEVICE

rapamycin-eluting stent

rapamycin-eluting stent was implanted due to randomisation

Trial Locations (2)

80636

Deutsches Herzzentrum Muenchen, Munich

81675

1. Medizinische Klinik, Klinikum rechts der Isar, München

All Listed Sponsors
lead

Deutsches Herzzentrum Muenchen

OTHER

NCT00402636 - Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE) | Biotech Hunter | Biotech Hunter